PURA2 Antibody

What is PURA2 and why are antibodies against it significant in research?

PURA2 (Adenylosuccinate synthetase 2) is an enzyme involved in purine biosynthesis, classified under EC=6.3.4.4 (IMP--aspartate ligase 2) . It appears to be primarily found in chloroplasts in plant species such as Capsicum frutescens (pepper), Physcomitrella patens, Sorghum bicolor, and Ricinus communis . Antibodies against PURA2 are significant in research because they allow for detection, quantification, and isolation of this enzyme for studying purine metabolism pathways in plants. Unlike PURA, which is implicated in the rare neurodevelopmental disorder PURA Syndrome and binds both DNA and RNA in human cells, PURA2 serves a distinct metabolic function in plants .

How do PURA2 antibodies differ from PURA antibodies in terms of target recognition and applications?

While both target proteins with similar names, they recognize entirely different biological molecules. PURA2 antibodies target Adenylosuccinate synthetase 2 (chloroplastic), whereas PURA antibodies target the RNA-binding protein PURA (Purine-rich single-stranded DNA-binding protein alpha) . The applications differ accordingly: PURA antibodies are used to study RNA-binding interactions, P-body formation, and neurodevelopmental processes, while PURA2 antibodies primarily facilitate research on chloroplastic purine metabolism . Research methodologies must account for these differences, as PURA is predominantly located in the cytoplasm in human cells where it binds thousands of mRNAs, while PURA2 is typically chloroplast-localized in plant species .

What validation criteria should be applied to confirm PURA2 antibody specificity?

Rigorous validation of PURA2 antibodies requires multiple complementary approaches:

• Western blot analysis showing a single band at the expected molecular weight (~44kDa for plant PURA2)

• Knockout/knockdown controls demonstrating reduced or absent signal

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Cross-reactivity testing against related proteins, especially PURA and other adenylosuccinate synthetases

• Peptide competition assays to confirm epitope specificity

For maximum reliability, researchers should implement iterative rounds of subtraction and affinity purification with stringent washes, similar to protocols used for developing highly specific antibodies against post-translationally modified proteins . This approach is particularly important given the potential cross-reactivity between different adenylosuccinate synthetase isoforms and other purine metabolism enzymes .

How can PURA2 antibodies be utilized in co-immunoprecipitation experiments to identify novel interaction partners?

Co-immunoprecipitation (Co-IP) using PURA2 antibodies provides a powerful approach to uncovering protein-protein interactions in purine metabolism pathways. A methodical approach includes:

• Sample preparation: Homogenize plant tissues in a low-stringency lysis buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 0.5% NP-40) with protease inhibitors.

• Pre-clearing: Incubate lysate with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

• Immunoprecipitation: Incubate 1mg of lysate with 6μg of PURA2 antibody overnight at 4°C, then add protein A/G beads for 2-4 hours (following similar antibody:lysate ratios as established for PURA IP) .

• Washing: Perform gentle washes to preserve weak interactions, using buffer with reduced detergent concentration.

• Elution and analysis: Elute complexes and analyze using mass spectrometry or western blotting.

This approach has successfully identified interaction networks for other proteins, such as PURA's association with stress granules and P-body components . Researchers should include IgG control antibody precipitations to identify non-specific binding partners and validate interactions through reciprocal Co-IP or proximity ligation assays .

What strategies can ensure specificity when using PURA2 antibodies in cross-species research?

When applying PURA2 antibodies across different plant species, researchers should implement a multi-faceted approach to ensure specificity:

• Epitope sequence analysis: Compare the immunogen sequence across target species using bioinformatics tools to predict cross-reactivity.

• Validation hierarchy:

  • Confirm antibody reactivity against recombinant PURA2 from each species

  • Verify single-band detection at the expected molecular weight

  • Perform knockout/knockdown controls where available

• Blocking strategies:

  • Pre-absorb antibodies with recombinant protein from non-target species to reduce cross-reactivity

  • Implement the iterative purification protocol described by Washington University researchers

• Analytical controls:

  • Run parallel detection with multiple antibodies recognizing different epitopes

  • Include gradient gels to resolve closely related isoforms

A cross-species validation table should be created for each PURA2 antibody:

This systematic approach ensures reliable cross-species application while documenting species-specific optimization parameters .

How can post-translational modifications of PURA2 be investigated using specialized antibody approaches?

Investigating post-translational modifications (PTMs) of PURA2 requires specialized antibody generation and purification techniques:

• PTM-specific antibody development:

  • Synthesize peptides with specific modifications (phosphorylation, acetylation, etc.)

  • Implement the iterative subtraction and affinity purification protocol described in Nature Protocols

  • Use stringent washes to remove antibodies recognizing unmodified protein

  • Verify specificity through dot blot and western blot comparing modified vs. unmodified protein

• Experimental approaches:

  • Immunoprecipitate PURA2 under various physiological conditions

  • Analyze PTM patterns by mass spectrometry

  • Perform western blots with PTM-specific antibodies

  • Use lambda phosphatase treatment as control for phosphorylation-specific antibodies

• Functional correlation:

  • Map PTM sites to functional domains of PURA2

  • Correlate PTM status with enzymatic activity

  • Investigate stimulus-dependent PTM changes

This approach, similar to methods used for other proteins, allows researchers to understand how PTMs regulate PURA2 activity in response to metabolic demands and environmental signals .

What are the optimal sample preparation methods for detecting PURA2 in plant tissues?

Efficient detection of chloroplastic PURA2 in plant tissues requires optimized extraction and preparation methods:

• Tissue collection timing:

  • Harvest tissues in the morning when chloroplast proteins are most abundant

  • Flash-freeze samples in liquid nitrogen to prevent protein degradation

  • Process all experimental conditions identically to ensure comparability

• Extraction buffer optimization:

  • Use chloroplast isolation buffer (330mM sorbitol, 50mM HEPES-KOH pH 7.8, 2mM EDTA)

  • Include protease inhibitor cocktail and 1mM DTT to prevent degradation and oxidation

  • Add 1% Triton X-100 for complete solubilization of membrane-associated PURA2

• Fractionation considerations:

  • Perform differential centrifugation to isolate intact chloroplasts

  • Use hypotonic lysis to separate stromal and thylakoid fractions

  • Compare whole tissue lysate with chloroplast fractions to confirm localization

• Sample denaturation:

  • Heat samples at 70°C rather than 95°C to prevent aggregation

  • Use fresh samples whenever possible, as freeze-thaw cycles reduce detection sensitivity

This methodical approach ensures maximum recovery of PURA2 while preserving its native characteristics, similar to careful preparation methods used for other chloroplastic proteins .

What are the recommended protocols for using PURA2 antibodies in western blotting applications?

For optimal PURA2 detection in western blotting, researchers should follow this protocol:

• Gel electrophoresis parameters:

  • Use 10-12% acrylamide gels for optimal resolution

  • Load 20-30μg of total protein per lane

  • Include recombinant PURA2 as positive control

  • Run at constant voltage (100V) for best resolution

• Transfer conditions:

  • Use PVDF membrane (0.45μm pore size) for stronger protein binding

  • Transfer at 100V for 1 hour in cold transfer buffer containing 20% methanol

  • Verify transfer efficiency with reversible staining

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with primary PURA2 antibody at 1:1000 dilution overnight at 4°C

  • Wash 5× with TBST for 5 minutes each

  • Incubate with HRP-conjugated secondary antibody at 1:5000 for 1 hour

• Detection optimization:

  • Use enhanced chemiluminescence with exposure times of 10-30 seconds

  • Capture images using a digital imaging system for quantification

  • Strip and reprobe for loading controls (RuBisCO for chloroplast fraction)

This protocol adapts established western blotting methods, similar to those successfully used for PURA detection, with specific modifications for chloroplastic proteins .

How should researchers approach the generation of monoclonal antibodies against PURA2?

Generating high-quality monoclonal antibodies against PURA2 requires systematic planning and execution:

• Immunogen design:

  • Select unique peptide sequences from PURA2 (20-21 amino acids) with high antigenicity

  • Avoid regions with high homology to related proteins

  • Consider using the unstructured linker region approach successful for PURA antibody 12D11

  • Couple peptide to carrier protein (KLH or ovalbumin) to enhance immunogenicity

• Immunization and hybridoma generation:

  • Immunize Sprague Dawley rats or BALB/c mice with ovalbumin-coupled peptide

  • Perform hybridoma fusion following established protocols

  • Screen antibody supernatants using solid-phase immunoassay with biotinylated PURA2 peptide

• Clone selection and validation:

  • Test clones by western blot on plant extracts with and without PURA2 knockdown

  • Perform subcloning by limiting dilution to obtain stable monoclonal cell lines

  • Validate final clones using multiple applications (WB, IP, IHC)

• Production and purification:

  • Culture selected hybridoma in serum-free medium

  • Purify antibodies using protein G affinity chromatography

  • Characterize binding parameters (affinity, specificity, cross-reactivity)

This approach mirrors the successful development of the PURA monoclonal antibody 12D11, which demonstrated high specificity in multiple applications .

What strategies can resolve weak or absent signals when detecting PURA2 in western blots?

When encountering weak or absent PURA2 signals in western blots, implement this systematic troubleshooting approach:

• Sample preparation optimization:

  • Verify protein extraction efficiency using fractionation controls

  • Check for protein degradation with fresh protease inhibitors

  • Optimize lysis buffer composition for chloroplast proteins

  • Avoid multiple freeze-thaw cycles of protein samples

• Detection sensitivity enhancement:

  • Increase protein loading (up to 50μg per lane)

  • Reduce antibody dilution (try 1:500 instead of 1:1000)

  • Extend primary antibody incubation to 48 hours at 4°C

  • Switch to more sensitive detection systems (e.g., SuperSignal West Femto)

• Membrane and transfer parameters:

  • Try both PVDF and nitrocellulose membranes to optimize binding

  • Reduce transfer time or voltage if protein is passing through membrane

  • Use wet transfer systems for more complete transfer of chloroplastic proteins

  • Add 0.1% SDS to transfer buffer to improve large protein transfer

• Antibody and blocking optimization:

  • Test alternative blocking agents (BSA instead of milk)

  • Reduce washing stringency slightly (reduce detergent concentration)

  • Try different antibody diluents with protein stabilizers

  • Consider using antibody enhancer solutions

This comprehensive approach addresses the most common causes of weak western blot signals, similar to troubleshooting methods employed for other chloroplastic proteins .

How can researchers address cross-reactivity issues between PURA2 and related proteins?

Addressing cross-reactivity between PURA2 and related proteins requires a multi-layered approach:

• Antibody purification strategies:

  • Implement the iterative subtraction protocol described by Washington University researchers

  • Pre-absorb antibody with recombinant related proteins (ADSS, other synthetases)

  • Perform affinity purification against specific PURA2 epitopes

  • Use stringent washes to remove low-affinity binding antibodies

• Analytical separation techniques:

  • Use high-resolution gels (6-8% acrylamide) to separate similar molecular weight proteins

  • Implement 2D gel electrophoresis to separate based on both size and isoelectric point

  • Consider blue native PAGE for intact protein complexes

  • Use gradient gels for optimal resolution

• Confirmatory approaches:

  • Run parallel blots with antibodies against related proteins

  • Include recombinant PURA2 and related proteins as controls

  • Perform peptide competition assays with specific PURA2 peptides

  • Validate with mass spectrometry of immunoprecipitated bands

• Genetic validation:

  • Use PURA2 knockdown or knockout tissues as negative controls

  • Perform complementation with tagged PURA2 for unambiguous identification

This systematic approach ensures reliable differentiation between PURA2 and related proteins, particularly important given the similar enzymatic functions of adenylosuccinate synthetase family members .

What considerations should be made when adapting PURA2 antibody protocols across different experimental systems?

Adapting PURA2 antibody protocols across different experimental systems requires careful consideration and optimization:

• Species-specific adaptations:

  • Adjust antibody concentration based on PURA2 expression levels in each species

  • Modify extraction buffers according to tissue composition (higher detergent for woody tissues)

  • Validate epitope conservation through sequence alignment before experimentation

  • Establish species-specific positive controls

• Application-specific modifications:

  • For immunohistochemistry: optimize fixation methods (4% PFA for herbaceous tissues, Carnoy's for woody tissues)

  • For immunofluorescence: implement autofluorescence quenching steps specific to plant tissues

  • For flow cytometry: adjust permeabilization conditions for chloroplast membranes

  • For ELISA: determine optimal coating concentration with recombinant PURA2

• Technical parameter adjustment table:

• Experimental design considerations:

  • Include appropriate controls for each new system

  • Perform pilot experiments with multiple conditions

  • Document optimization parameters systematically

  • Consider the impact of developmental stage and environmental conditions

This structured approach facilitates successful adaptation of PURA2 antibody protocols across different experimental systems while maintaining experimental rigor .